Combining Imaging and Endovascular Therapy into the CLI Clinical Algorithm: Live Case Presentation from AMP 2019

Combining Imaging and Endovascular Therapy into the CLI Clinical Algorithm: Live Case Presentation from AMP 2019

On-Demand Webcast
FACULTY

Live Case Operator:

Fadi Saab, MD
Chief Operations Officer
Advanced Cardiac & Vascular Centers for Amputation Prevention
Grand Rapids, Michigan 

Moderator:

Jihad Mustapha, MD
Co-founder and CEO
Advanced Cardiac & Vascular Centers for Amputation Prevention
Grand Rapids, Michigan

Panelists:

Marianne Brodmann, MD
Substitute Head of Division of Angiology
Medical University Graz
Graz, Austria

Craig Walker, MD
Clinical Professor of Medicine
Tulane Medical School Cardiovascular Institute of the South
Houma, Louisiana

George Adams, MD
Interventional Cardiology Director Cardiovascular and Peripheral Vascular Research
UNC REX Healthcare
University of North Carolina Chapel Hill Medical Center
Raleigh, North Carolina

Bryan Fisher, MD
Chief of Vascular Surgery
Centennial Medical Center
Nashville, Tennessee

PROVIDER STATEMENT

 Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.

INTENDED LEARNERS

This activity is designed for interventional cardiologists, vascular surgeons, interventional radiologists, wound care specialists, podiatrists, nurses, vascular technologists, and cardiovascular catheterization laboratory team members.

CLAIMING CREDIT

This on-demand webcast is available with video and audio.

In order to be eligible for documentation of credit, participants must attend the full webcast, complete the post-test with a score of 75% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release Date: September 30, 2019
Expiration Date: September 30, 2020
Estimated time to complete: 1 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

CONTINUING EDUCATION

  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

PHYSICIANS

NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING

This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 credit.

PAs should only claim credit commensurate with the extent of their participation.

PODIATRISTS

NACCME is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. 

NACCME has approved this activity for a maximum of 1.0 continuing education contact hour.

VASCULAR & INTERVENTIONAL RADIOGRAPHERS

Combining Imaging and Endovascular Therapy into the CLI Clinical Algorithm: Live Case Presentation from AMP 2019 has been submitted and is pending approval for 1.0 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). 

The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewer:

Jos C. van den Berg
Ospedale Regionale di Lugano sede Civico University of Bern
Lugano, Switzerland

Planning Committee

The planning committee comprises Fadi Saab, MD; Jihad Mustapha, MD; Marianne Brodmann, MD; George Adams, MD; Bryan Fisher, MD; Craig Walker, MD; and MaryEllen Fama, Caitlin Eastman, Jennifer Ilcyn, Colleen Waters, and Chris Bolwell, NACCME.

The faculty has reported the following:

Dr. Saab: Consultant - BD Bard, Boston Scientific, Cardiovascular Systems, Inc, Gore, Medtronic, Philips, Terumo;  Grant/Research Support - Boston Scientific, CardioFlow, PQ Bypass

Dr. Mustapha: Consultant - BD Bard, Boston Scientific, Cardiovascular Systems, Inc., Medtronic, Philips, Terumo, PQ Bypass; Grant/Research Support - Boston Scientific, CardioFlow, PQ Bypass; Major Stock Shareholder - CardioFlow

Dr. Adams: Consultant - Abbott Vascular, Asahi Intecc, Bard, Boston Scientific, Cardinal Health, Cardiovascular Systems Inc., Control Medical, Cook Medical, CloSys, Daiichi Sankyo, Gore, Intact Vascular, Lake Region Medical, Marine Polymer Technologies, Medtronic, Mercator Med-Systems, Meril, Penumbra, Philips, Shockwave Medical, Soundbite, Surmodics, Terumo;  Grant/ Research Support - Abbott Vascular, Bard, Boston Scientific, Cardiovascular Systems Inc., Cook Medical, CloSys, Daiichi Sankyo, Gore, Intact Vascular, Lake Region Medical, Marine Polymer Technologies, Medtronic, Mercator Med-Systems, Penumbra, Philips, Shockwave Medical, Soundbite, Surmodics; Speakers’ Bureau - Abbott Vascular, Asahi Intecc, Cardiovascular Systems Inc., Control Medical, Cook Medical, Gore, Intact Vascular, Lake Region Medical, Marine Polymer Technologies, Medtronic, Mercator Med-Systems, Penumbra, Philips, Shockwave Medical, Soundbite

Dr. Brodmann: Consultant – Intact Vascular, Medtronic, BD Bard, Philips Spectranetics, Cagent; Speakers’ Bureau – Intact Vascular, Medtronic, BD Bard, Philips Spectranetics, Cagent, Daiichi Sankyo, Bayer Healthcare

Dr. Fisher: Consultant – Philips, Abbott, Cordis, Cook; Speakers’ Bureau – Cordis

Dr. Walker: Speaker’s Bureau – Philips/Volcano, Amgen, Janssen Pharmaceuticals

Ms. Fama, Ms. Eastman, Ms. Ilcyn, Ms. Waters, and Mr. Bolwell have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

EDUCATIONAL GRANT SUPPORT

This activity is supported by an educational grant from Philips IGT.